We are excited to announce the Dynavax DV3-MEL-01 study for metastatic or advanced melanoma is now open to recruitment (and we have already recruited our first patient!).  More information about the study can be found here.

If you would to discuss this study, you can speak to our oncology nurses on (08) 9446 8726 or email us info@affinityresearch.com.au .



Affinity Clinical Research Services Newsletter

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.


You have Successfully Subscribed!